C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Purchases New Position in Chemed Co. (NYSE:CHE)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Chemed Co. (NYSE:CHE) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,794 shares of the company’s stock, valued at approximately $2,540,000.

Several other institutional investors and hedge funds also recently modified their holdings of CHE. Van ECK Associates Corp boosted its stake in shares of Chemed by 30.4% in the fourth quarter. Van ECK Associates Corp now owns 15,141 shares of the company’s stock valued at $8,022,000 after purchasing an additional 3,531 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in Chemed by 9.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 46,052 shares of the company’s stock worth $24,314,000 after buying an additional 3,785 shares in the last quarter. Schwartz Investment Counsel Inc. boosted its position in Chemed by 1.0% in the 4th quarter. Schwartz Investment Counsel Inc. now owns 119,163 shares of the company’s stock valued at $63,133,000 after buying an additional 1,173 shares during the last quarter. Portfolio Design Labs LLC acquired a new stake in shares of Chemed during the fourth quarter valued at about $324,000. Finally, Elevate Capital Advisors LLC purchased a new stake in shares of Chemed during the fourth quarter worth about $1,106,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Shares of Chemed stock opened at $549.51 on Thursday. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $654.62. The firm’s 50-day simple moving average is $542.24 and its 200-day simple moving average is $564.74. The firm has a market cap of $8.27 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 2.16 and a beta of 0.48.

Insider Buying and Selling at Chemed

In other news, VP Brian C. Judkins purchased 145 shares of the stock in a transaction dated Monday, December 30th. The stock was acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now owns 1,678 shares of the company’s stock, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the transaction, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts recently commented on CHE shares. Royal Bank of Canada reduced their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.